Passage Bio chips away at workforce, prioritizes R&D with UPenn’s James Wilson
Passage Bio chips away at workforce, prioritizes R&D with UPenn’s [...]
Passage Bio chips away at workforce, prioritizes R&D with UPenn’s [...]
Moderna hits the gas as it begins dosing of 2nd [...]
CAMP4 poaches Translate Bio medical chief, adds ex-Biogen R&D leader [...]
Ascendis scores in phase 3 trial as it looks to [...]
Concert tunes pipeline by selling off CNS assets to startup [...]
Immunome’s COVID-19 antibody cocktail back on track for phase 1 [...]
AbbVie doubles down on Gedeon Richter pact that brought Vraylar [...]
Histogen seeks to tear up COVID-19 R&D pact and go [...]
Harpoon drug sunk by modest activity, challenging tolerability, forcing pivot [...]
Orphazyme on last leg as court-mediated restructuring drives another wave [...]